Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
CONCLUSION: The TF-targeted NIR-PIT with the 1849-ICG conjugate can potentially open a new platform for treatment of TF-expressing pancreatic cancer.
PMID: 30622378 [PubMed - in process]
Source: World Journal of Gastroenterology - Category: Gastroenterology Authors: Aung W, Tsuji AB, Sugyo A, Takashima H, Yasunaga M, Matsumura Y, Higashi T Tags: World J Gastroenterol Source Type: research
More News: Cancer | Cancer & Oncology | Gastroenterology | Pancreas | Pancreatic Cancer | Statistics